The Vanguard Group 13D and 13G filings for Vertex Pharmaceuticals Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:17 pm Purchase | 2023-12-29 | 13G | Vertex Pharmaceuticals Incorporated VRTX | The Vanguard Group | 22,281,729 8.650% | 734,826 (+3.41%) | Filing |
| 2023-02-09 11:35 am Purchase | 2022-12-30 | 13G | Vertex Pharmaceuticals Incorporated VRTX | The Vanguard Group | 21,546,903 8.390% | 1,391,061 (+6.90%) | Filing |
| 2022-02-10 08:42 am Sale | 2021-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX | The Vanguard Group | 20,155,842 7.930% | -277,208 (-1.36%) | Filing |
| 2021-02-10 12:00 pm Purchase | 2020-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX | The Vanguard Group | 20,433,050 7.860% | 338,816 (+1.69%) | Filing |
| 2020-02-12 09:27 am Purchase | 2019-12-31 | 13G | Vertex Pharmaceuticals Incorporated VRTX | The Vanguard Group | 20,094,234 7.810% | 705,043 (+3.64%) | Filing |